<SEC-DOCUMENT>0001178913-23-001109-index.html : 20230323
<SEC-HEADER>0001178913-23-001109.hdr.sgml : 20230323
<ACCEPTANCE-DATETIME>20230323073327
ACCESSION NUMBER:		0001178913-23-001109
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230316
FILED AS OF DATE:		20230323
DATE AS OF CHANGE:		20230323

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Darvish Nissim
		CENTRAL INDEX KEY:			0001793602

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		23754476

	MAIL ADDRESS:	
		STREET 1:		C/O INNOVATE BIOPHARMACEUTICALS, INC.
		STREET 2:		8480 HONEYCUTT ROAD, SUITE 120
		CITY:			RALEIGH
		STATE:			NC
		ZIP:			27615

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>zk2329427.xml
<TEXT>
Document 1 - file: zk2329427.html

Document 1 - RAW XML: zk2329427.xml

</DOCUMENT>
</SEC-DOCUMENT>